Specialists for Inhalational anthrax

25 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Alex King, MD
Rare Disease / Clinical Research
Covance
QC-verified PI×2 1
David Mathews, MD
Rare Disease / Clinical Research
Quintiles, Inc.
QC-verified PI×2
Lori Sieboldt, MD, MD
Rare Disease / Clinical Research
Covance Clinical Research - Evansville, IN
EVANSVILLE, IN
QC-verified PI×1 1
H. Frank Farmer, PhD, MD
Rare Disease / Clinical Research
Covance Research - Daytona Beach, Fl
QC-verified PI×1
Alan S Marion, MD, PhD
Rare Disease / Clinical Research
MDS Pharma Services
QC-verified PI×1
Jolene Berg, MD, M.D
Rare Disease / Clinical Research
Davita Clinical Research
EDINA, MN
QC-verified PI×1
Debra Mandarino, MD, md
Rare Disease / Clinical Research
Covance Research, Madison, WI
MADISON, WI
PI×2
Tammy D Jenkins
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Sherry L Rippeon
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
James E Miller
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Derek Toth, LISW-CP
Emergent BioSolutions Canada (Previously Cangene Corporation)
2
Jeremy A Boydston
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Srinivas Kammanadiminti
Rare Disease / Clinical Research
Emergent BioSolutions Canada (Previously Cangene Corporation)
2
Allison M Ferris
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
LIBERTY, MO
1
David G Dawson
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Melissa L Krause
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Charles L Balzli
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Victoria Wahl
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
John J Yeager, Masters of Science
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
BEL AIR, MD
1
Jordan K Bohannon
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Shantha Kodihalli
Rare Disease / Clinical Research
Emergent BioSolutions Canada (Previously Cangene Corporation)
2
Andrea B Eyler
Rare Disease / Clinical Research
National Biodefense Analysis and Countermeasures Center
1
Brandon Essink, M.D
CREIGHTON, NE
QC-verified PI×1
Oscar Della Pasqua
Rare Disease / Clinical Research
Clinical Pharmacology & Therapeutics Group
PI×1 2
Sean P Oosterholt
Rare Disease / Clinical Research
Clinical Pharmacology & Therapeutics Group
2

More about Inhalational anthrax